These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31484740)

  • 1. Deletion of a Single LeishIF4E-3 Allele by the CRISPR-Cas9 System Alters Cell Morphology and Infectivity of
    Shrivastava R; Tupperwar N; Drory-Retwitzer M; Shapira M
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31484740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LeishIF4E1 Deletion Affects the Promastigote Proteome, Morphology, and Infectivity.
    Tupperwar N; Shrivastava R; Shapira M
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31722993
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of an Atypical eIF4E Ortholog in
    Tupperwar N; Shrivastava R; Baron N; Korchev O; Dahan I; Shapira M
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884522
    [No Abstract]   [Full Text] [Related]  

  • 4. Nutritional stress targets LeishIF4E-3 to storage granules that contain RNA and ribosome components in Leishmania.
    Shrivastava R; Drory-Retwitzer M; Shapira M
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007237. PubMed ID: 30870425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LeishIF4E-5 Is a Promastigote-Specific Cap-Binding Protein in
    Shrivastava R; Tupperwar N; Schwartz B; Baron N; Shapira M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921489
    [No Abstract]   [Full Text] [Related]  

  • 6. Nutritional stress affects an atypical cap-binding protein in Leishmania.
    Zinoviev A; Manor S; Shapira M
    RNA Biol; 2012 Dec; 9(12):1450-60. PubMed ID: 23135001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding specificities and potential roles of isoforms of eukaryotic initiation factor 4E in Leishmania.
    Yoffe Y; Zuberek J; Lerer A; Lewdorowicz M; Stepinski J; Altmann M; Darzynkiewicz E; Shapira M
    Eukaryot Cell; 2006 Dec; 5(12):1969-79. PubMed ID: 17041189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct features of the Leishmania cap-binding protein LeishIF4E2 revealed by CRISPR-Cas9 mediated hemizygous deletion.
    Baron N; Tupperwar N; Dahan I; Hadad U; Davidov G; Zarivach R; Shapira M
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0008352. PubMed ID: 33760809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 in Leishmania mexicana: A case study of LmxBTN1.
    Ishemgulova A; Hlaváčová J; Majerová K; Butenko A; Lukeš J; Votýpka J; Volf P; Yurchenko V
    PLoS One; 2018; 13(2):e0192723. PubMed ID: 29438445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 Mutagenesis in Phlebotomus papatasi: the Immune Deficiency Pathway Impacts Vector Competence for Leishmania major.
    Louradour I; Ghosh K; Inbar E; Sacks DL
    mBio; 2019 Aug; 10(4):. PubMed ID: 31455654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose Transporters and Virulence in
    Feng X; Tran KD; Sanchez MA; Al Mezewghi H; Landfear SM
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30068561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A newly identified Leishmania IF4E-interacting protein, Leish4E-IP2, modulates the activity of cap-binding protein paralogs.
    Tupperwar N; Meleppattu S; Shrivastava R; Baron N; Gilad A; Wagner G; Léger-Abraham M; Shapira M
    Nucleic Acids Res; 2020 May; 48(8):4405-4417. PubMed ID: 32232353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel 4E-interacting protein in Leishmania is involved in stage-specific translation pathways.
    Zinoviev A; Léger M; Wagner G; Shapira M
    Nucleic Acids Res; 2011 Oct; 39(19):8404-15. PubMed ID: 21764780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cap-binding activity of an eIF4E homolog from Leishmania.
    Yoffe Y; Zuberek J; Lewdorowicz M; Zeira Z; Keasar C; Orr-Dahan I; Jankowska-Anyszka M; Stepinski J; Darzynkiewicz E; Shapira M
    RNA; 2004 Nov; 10(11):1764-75. PubMed ID: 15388875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of clan CD C11 peptidase PNT1 and other Leishmania mexicana cysteine peptidases as potential drug targets.
    Grewal JS; Catta-Preta CMC; Brown E; Anand J; Mottram JC
    Biochimie; 2019 Nov; 166():150-160. PubMed ID: 31472179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the gene for the membrane-bound acid phosphatase of Leishmania mexicana.
    Benzel I; Weise F; Wiese M
    Mol Biochem Parasitol; 2000 Nov; 111(1):77-86. PubMed ID: 11087918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoglycan repeat-deficient Leishmania mexicana parasites remain infectious to macrophages and mice.
    Ilg T; Demar M; Harbecke D
    J Biol Chem; 2001 Feb; 276(7):4988-97. PubMed ID: 11071892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A putative ATP/GTP binding protein affects Leishmania mexicana growth in insect vectors and vertebrate hosts.
    Ishemgulova A; Kraeva N; Hlaváčová J; Zimmer SL; Butenko A; Podešvová L; Leštinová T; Lukeš J; Kostygov A; Votýpka J; Volf P; Yurchenko V
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005782. PubMed ID: 28742133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of meta 1 expression with culture stage, cell morphology and infectivity in Leishmania (Leishmania) amazonensis promastigotes.
    Santos MG; Silva MF; Zampieri RA; Lafraia RM; Floeter-Winter LM
    Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):190-3. PubMed ID: 21537679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of E-NTPdases during Leishmania amazonensis lifecycle and effect of their overexpression on parasite infectivity and virulence.
    Paes-Vieira L; Rocco-Machado N; Freitas-Mesquita AL; Dos Santos Emiliano YS; Gomes-Vieira AL; de Almeida-Amaral EE; Meyer-Fernandes JR
    Parasitol Int; 2021 Dec; 85():102423. PubMed ID: 34298165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.